Matches in Wikidata for { <http://www.wikidata.org/entity/Q37679341> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q37679341 description "article científic" @default.
- Q37679341 description "article scientifique" @default.
- Q37679341 description "articolo scientifico" @default.
- Q37679341 description "artigo científico" @default.
- Q37679341 description "artículu científicu espublizáu en 2010" @default.
- Q37679341 description "bilimsel makale" @default.
- Q37679341 description "scientific article published on 25 January 2010" @default.
- Q37679341 description "vedecký článok" @default.
- Q37679341 description "vetenskaplig artikel" @default.
- Q37679341 description "videnskabelig artikel" @default.
- Q37679341 description "vědecký článek" @default.
- Q37679341 description "wetenschappelijk artikel" @default.
- Q37679341 description "wissenschaftlicher Artikel" @default.
- Q37679341 description "наукова стаття, опублікована в січні 2010" @default.
- Q37679341 description "научни чланак" @default.
- Q37679341 description "مقالة علمية نشرت في 25 يناير 2010" @default.
- Q37679341 name "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 name "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 name "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 type Item @default.
- Q37679341 label "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 label "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 label "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 prefLabel "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 prefLabel "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 prefLabel "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 P1433 Q37679341-45B5CB1A-6E7F-4C37-BEFC-E0ADF483F15B @default.
- Q37679341 P1476 Q37679341-8F9DD487-CC6F-4CC3-9D85-0D43D546BF4F @default.
- Q37679341 P2093 Q37679341-C4A05C62-BC14-4925-B46C-0E40165FA04C @default.
- Q37679341 P2093 Q37679341-DCA69A85-6D5D-4DB4-A5F3-B64BC2A98A8B @default.
- Q37679341 P2860 Q37679341-11360016-12B1-4ACF-ABF6-2F45799EF763 @default.
- Q37679341 P2860 Q37679341-C7E6D760-E1C0-4CCE-B524-4B9433AA421C @default.
- Q37679341 P304 Q37679341-C557DB42-1A29-4EA9-8A63-5AB20DDD1730 @default.
- Q37679341 P31 Q37679341-1FFD932C-B9AE-4DCF-A508-FE1F21D32908 @default.
- Q37679341 P31 Q37679341-f76dbc4a-a30b-465f-9699-55e6f842f7a0 @default.
- Q37679341 P356 Q37679341-93AF4E27-5E6A-4CB4-92C2-71E147CACF1F @default.
- Q37679341 P433 Q37679341-09ECEA4E-7D72-4C67-8ACA-B10D7CDC7640 @default.
- Q37679341 P478 Q37679341-768E9B02-BE5C-4ED8-9270-235C24FFA705 @default.
- Q37679341 P50 Q37679341-10EFBA4B-0783-4266-AFA6-4EA848EE928D @default.
- Q37679341 P50 Q37679341-D9D8EDAA-60FF-4677-8560-49F278EFA1E5 @default.
- Q37679341 P50 Q37679341-F57B5F60-DC4F-46E6-9962-38D96ED03D61 @default.
- Q37679341 P577 Q37679341-8332918A-54AB-43EC-A0BE-AE14612D67E9 @default.
- Q37679341 P5875 Q37679341-E86CBFCE-66C3-40B9-9810-D63B5D8CE9A3 @default.
- Q37679341 P698 Q37679341-27413C6F-905A-4E43-94BF-1588115716A7 @default.
- Q37679341 P921 Q37679341-3A3E9229-5644-4F54-9A55-6517CDDF8351 @default.
- Q37679341 P356 J.LUNGCAN.2009.12.009 @default.
- Q37679341 P698 20092908 @default.
- Q37679341 P1433 Q641464 @default.
- Q37679341 P1476 "New strategies to overcome limitations of reversible EGFR tyrosine kinase inhibitor therapy in non-small cell lung cancer" @default.
- Q37679341 P2093 "Ana B Oton" @default.
- Q37679341 P2093 "Nir Peled" @default.
- Q37679341 P2860 Q27851406 @default.
- Q37679341 P2860 Q42652476 @default.
- Q37679341 P304 "1-12" @default.
- Q37679341 P31 Q13442814 @default.
- Q37679341 P31 Q7318358 @default.
- Q37679341 P356 "10.1016/J.LUNGCAN.2009.12.009" @default.
- Q37679341 P433 "1" @default.
- Q37679341 P478 "69" @default.
- Q37679341 P50 Q101577859 @default.
- Q37679341 P50 Q114292043 @default.
- Q37679341 P50 Q88321795 @default.
- Q37679341 P577 "2010-01-25T00:00:00Z" @default.
- Q37679341 P5875 "41111017" @default.
- Q37679341 P698 "20092908" @default.
- Q37679341 P921 Q47912 @default.